WTO

3 - UTime Ltd (0001789299) (Issuer)

3 - UTime Ltd (0001789299) (Issuer)

3 - UTime Ltd (0001789299) (Issuer)

6-K - UTime Ltd (0001789299) (Filer)

6-K - UTime Ltd (0001789299) (Filer)

SHENZHEN, China, March 13, 2026 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO), a global technology company engaged in the design, development, and manufacturing of mobile devices and smart hardware products, today announced its intention to acquire 100% of the outstanding equity of Feixiaohao Technology Inc., operator of the renowned "Feixiaohao" Web3 Data Analytics & Asset Pricing Platform (feixiaohao.ai). The proposed transaction is valued at up to USD80 million, structured through a combination of USD64 million in UTime ordinary shares or convertible preferred shares and USD16 million in cash consideration. This intended acquisition, upon completion, will mark UTime's strategic entry

SHENZHEN, China, Feb. 06, 2026 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO) today announced that its share consolidation ("Share Consolidation") involving the consolidation of every five (5) Class A ordinary shares, with a par value of US$0.10 per share, into one (1) class A ordinary share with a par value of US$0.50 per share, will take effect at 8:00 a.m. Eastern Time on February 17, 2026. The Company's Class A Ordinary shares will open for trading on the Nasdaq Capital Market on February 17, 2026, on a post-split basis, under the existing ticker symbol "WTO," with a new CUSIP number of G9411M140. Details of the Share Consolidation The Share Consolidation was approved by the Company'

SHENZHEN, China, Feb. 03, 2026 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO), a global technology company engaged in the design, development, and manufacturing of mobile devices and smart hardware products, today announced that its Shenzhen-based subsidiary, Shenzhen Liandai Technology Co., Ltd. ("Shenzhen Liandai"), has entered into a strategic Intentional Order Cooperation Agreement (the "Cooperation Agreement") with Shenzhen Yunwei Digital Technology Co., Ltd. ("Shenzhen Yunwei Digital") for the potential supply of 500,000 units of smart servers, representing an estimated contract value of approximately $50 million. Under the Cooperation Agreement, Shenzhen Yunwei Digital has expresse

6-K - UTime Ltd (0001789299) (Filer)

6-K - UTime Ltd (0001789299) (Filer)

6-K - UTime Ltd (0001789299) (Filer)

6-K - UTime Ltd (0001789299) (Filer)

SHENZHEN, China, Dec. 31, 2025 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO), a global technology company engaged in the design and development of mobile devices today announced a major commercial breakthrough. UTime's Hong Kong subsidiary, UTime Technology (HK) Company Limited, has officially signed a smart health device procurement agreement worth nearly $10 million USD with Tumu Vertex LLC, a Denver-based entity, marking a crucial step in UTime's strategic deployment in the North American medical-grade smart wearable market. Under the signed Sales Agreement, Tumu Vertex LLC has placed an initial purchase order for 50,000 premium smart health devices from UTime, comprising: 25,000 uni

6-K - UTime Ltd (0001789299) (Filer)

6-K - UTime Ltd (0001789299) (Filer)

SHENZHEN, China, Nov. 12, 2025 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO) today announced that it will implement a reverse stock split of its common shares at a ratio of 1-for-100, effective 12:01 a.m. Eastern Time on November 21, 2025. UTime's Class A ordinary shares will begin trading on Nasdaq on a split-adjusted basis at market open on November 21, 2025 under the ticker symbol "WTO." The reverse split is intended to increase the per-share trading price of UTime's Class A ordinary shares to help the Company regain compliance with Nasdaq's minimum bid price requirement and better position the stock for long-term growth and institutional participation. No fractional shares will be i

6-K - UTime Ltd (0001789299) (Filer)

SHENZHEN, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO) today announced that it is actively promoting its smart wearable devices to more international markets through its existing global distribution channels and partner network. Leveraging its experience in supply chain management and product development accumulated in the mobile device sector, the company is committed to introducing its newly launched health-focused smart wearable products, including smartwatches and smart rings, to multiple overseas markets where it has established business connections. The company believes that its products' balance of functional design and cost-effectiveness will help them gai

6-K - UTime Ltd (0001789299) (Filer)

SHENZHEN, China, Nov. 03, 2025 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO) today outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial intelligence (AI) technologies. UTime is developing AI-based algorithm models aimed at performing in-depth analysis of continuous physiological data collected from smart wearable devices such as watches and rings. Current research directions include: building hypertension risk assessment models by integrating multi-parameter data like blood pressure, heart rate, activity and sleep; and conducting trend assessments of users' cardiovascular system health status by analyzing features s

6-K - UTime Ltd (0001789299) (Filer)

SHENZHEN, China, Oct. 30, 2025 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO) today released its smart ring product. Utilizing the advantage of unnoticeable wear, the product aims to provide users with nighttime and long-term continuous health data monitoring. This smart ring features a precise and compact design, capable of monitoring multiple physiological parameters including skin temperature, blood oxygen saturation (SpO2), respiratory rate, and heart rate variability (HRV). Its key application scenario is sleep quality assessment, aiming to generate more detailed sleep analysis reports by collecting data unobtrusively during user sleep. Additionally, the product focuses on daily ac

6-K - UTime Ltd (0001789299) (Filer)

SHENZHEN, China, Oct. 28, 2025 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ:WTO), a global technology company engaged in the design and development of mobile devices, today announced the launch of a smartwatch with integrated blood pressure monitoring functionality, further expanding its product portfolio in the health technology sector. The product utilizes the Oscillo metric method, a market-validated measurement principle, and integrates a micro air pump and high-precision pressure sensor to provide users with a convenient blood pressure monitoring experience. It has obtained China NMPA Class II Medical Device Registration Certificate (Registration Certificate No.: Guangdong Instrument

6-K/A - UTime Ltd (0001789299) (Filer)